Nima Norbu Sherpa

Mr. Sherpa possesses a distinguished dual specialisation encompassing Psychopharmacology and Diagnostic Radiography. His comprehensive training in Diagnostic Imaging was undertaken at Glasgow Caledonian University and within the NHS Greater Glasgow and Clyde Board, Scotland.

Notably, his seminal research established the world's inaugural creatine-assisted psychotherapy trial for major depressive disorder. In 2024, his scholarly contributions were further recognised through the prestigious George and Dorothy Irving Magnusson Award, facilitating advanced training in Network Meta-Analysis at the Precision Psychiatry Lab, Department of Psychiatry, University of Oxford.

Presently, Mr. Sherpa is engaged in pioneering research investigating the therapeutic potential of a novel neurostimulation methodology, specifically Transcranial Ultrasound Stimulation (TUS), in the treatment of addiction. This endeavour is conducted under the expert supervision of Dr. Nadège Bault and Professor Elsa Fouragnan.

Concurrently, Mr. Sherpa maintains active collaborative relationships with Dr. Will Lawn of King's College London, and Dr. Riccardo De Giorgi, MD, MRCP, PhD, from the Department of Psychiatry, University of Oxford.

Furthermore, Mr. Sherpa contributes substantively to academic discourse and professional development through his roles as an Assistant Editor for "Mental Health Religion and Culture" (Taylor & Francis Online) and as a member of the Editorial Board for "Insight," the official CPD publication of the Society and College of Radiographers UK.